Co -delivery of doxorubicin and epacadostat via heparin coated pH -sensitive to the metastasis of melanoma
Co -delivery of doxorubicin and epacadostat via heparin coated pH -sensitive to the metastasis of melanoma
复制标题
DOI:
10.1016/j.ijpharm.2020.119446
复制
发表时间:
2020-06-30
影响因子:
5.8
通讯作者:
Peng, Jianqing
中科院分区:
文献类型:
--
作者:
Chen, Yi;Du, Qianming;Peng, Jianqing
High metastasis is responsible for the failure in the treatment of melanoma. Chemoimmunotherapy has shown conspicuous inhibition effects not only on the growth of tumor in situ, but also on the metastasis to distant organs. Given that the indoleamine-2,3 dioxygenase (IDO) overexpressed in the microenvironment of tumor leads to the immune escape, the combination of chemotherapeutic drug and IDO inhibitor might be a promising chemoimmunotherapy. Besides, the hematogenous metastasis mediated by platelets was supposed to be blocked by the heparin (HP). Therefore, a drug delivery system with all these elements involved might be a potential treatment for melanoma. Here, we developed a pH-sensitive liposomal dual-delivery system for doxorubicin (DOX) and epacadostat (EPA) with HP coated (HP/LDE). It was confirmed to enhance cytotoxicity and apoptosis, reverse the platelets-activated epithelial mesenchymal transformation (EMT) and prevent the invasion and migrationin vitro. After systemic administration, HP/LDE provided the optimum anti-metastasis effect on the melanoma. The results of evaluation on DC maturation, CD8+cytotoxic T lymphocytes (CTLs) activation and T cell mediated cytotoxicity were consistentin vitroandin vivo. Taken together, our study established a functional liposomal dual-delivery system with ideal anti-metastasis efficacy on melanoma.